Ubs Group Ag Abbott Laboratories Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

30 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $21.8 Million - $25.8 Million	218,100 Added 44.04%	713,300 $81.3 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $13.4 Million - $15 Million	-133,100 Reduced 21.18%	495,200 $51.5 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $16.2 Million - $17.9 Million	-147,748 Reduced 19.04%	628,300 $71.4 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $41.9 Million - $51.3 Million	464,448 Added 149.05%	776,048 $85.4 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $1.24 Million - $1.49 Million	13,000 Added 4.35%	311,600 $30.2 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $9.91 Million - $11 Million	98,300 Added 49.08%	298,600 $32.6 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $687,706 - $809,471	7,100 Added 3.67%	200,300 $20.3 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $4.38 Million - $5.14 Million	-46,100 Reduced 19.26%	193,200 $21.2 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $16.4 Million - $19 Million	170,000 Added 245.31%	239,300 $23.2 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $1.79 Million - $2.16 Million	17,500 Added 33.78%	69,300 $7.53 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $43.7 Million - $53.3 Million	-383,300 Reduced 88.09%	51,800 $6.13 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $18.5 Million - $22.6 Million	-159,967 Reduced 26.88%	435,100 $61.2 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $13.4 Million - $14.8 Million	115,000 Added 23.95%	595,067 $70.3 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $5.9 Million - $6.95 Million	-55,800 Reduced 10.41%	480,067 $55.7 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $25.4 Million - $29.9 Million	232,967 Added 76.91%	535,867 $64.2 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $8.28 Million - $9.03 Million	78,900 Added 35.22%	302,900 $33.2 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $357,396 - $434,031	3,900 Added 1.77%	224,000 $24.4 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $13.3 Million - $17 Million	173,100 Added 368.3%	220,100 $20.1 Million
Q1 2020 May 01, 2020	SELL	$62.82 - $91.86 $7.16 Million - $10.5 Million	-114,000 Reduced 70.81%	47,000 $3.71 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $8.46 Million - $9.42 Million	107,800 Added 202.63%	161,000 $14 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $220,968 - $239,598	2,700 Added 5.35%	53,200 $4.45 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $36,440 - $42,500	-500 Reduced 0.98%	50,500 $4.25 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $331,100 - $400,300	-5,000 Reduced 8.93%	51,000 $4.08 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $65,560 - $74,270	1,000 Added 1.82%	56,000 $4.05 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $814,854 - $983,024	13,400 Added 32.21%	55,000 $4.04 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $316,635 - $349,470	-5,500 Reduced 11.68%	41,600 $2.54 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $2.51 Million - $2.84 Million	44,600 Added 1784.0%	47,100 $2.82 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $72,090 - $80,460	1,500 Added 150.0%	2,500 $133,000
Q2 2017 Aug 14, 2017	SELL	N/A	-10,000 Reduced 90.91%	1,000 $49,000
Q1 2017 Nov 14, 2017	BUY	N/A	11,000	11,000 $488,000

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$18.9 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.7 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.62 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.38 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$5.99 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account